Clinical Trial Update: NeuroCytotron in the Treatment of Autism Spectrum Disorder [NA]

View source ↗

Summary

This clinical trial update indicates that NeuroCytotron is being studied for autism spectrum disorder and is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• NeuroCytotron

Snippet

Sponsor: Neurocytonix, Inc. | Conditions: Autism Spectrum Disorder | NA | Status: RECRUITING